PARAMETer: A window of opportunity study of Patritumab Deruxtecan in patients with brain metastases
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Daiichi Sankyo Inc
Start Date
May 18, 2022
End Date
June 30, 2026
Administered By
Duke Cancer Institute
Awarded By
Daiichi Sankyo Inc
Start Date
May 18, 2022
End Date
June 30, 2026